Methyl 2-[3,5-bis(trifluoromethyl)phenoxy]acetate, 5g

Ethyl 5-amino-6-methylnicotinate, 95.0%, 10g

3-Decyldihydrofuran-2,5-dione, 98%, 5g

7-Methyl-1H-indole-2-carboxylic acid, 95.0%, 5g

6-Methoxy-1,2,3,4-tetrahydroisoquinoline-4-carboxylic acid, 95+%, 250mg

Bis(4-(2,4,4-trimethylpentan-2-yl)phenyl)amine, 90.0%, 5g

Microliter syringe GASTIGHT® series 1700 Point type 3, 100 µl, 1710 RNR, 1 piece

5,7-Dichloro-2-isopropyl-2H-pyrazolo[4,3-d]pyrimidine, 95.0%, 250mg

Di-tert-butyl diethylphosphoramidite, 95.0%, 10g

2-Ethyl-4,5,6,7-tetrahydro-2h-indazol-3-amine, 95+%, 250mg

7-BROMO-1H-INDOLE-3-CARBALDEHYDE, 95.0%, 25g

N'-(2-METHOXYPHENYL)ACETOHYDRAZIDE, 95.0%, 250mg

(R)-1-(2-Fluorobenzyl)-3-(pyrrolidin-3-yl)urea hydrochloride, 1g